MedPath

HYALURONIC ACID SODIUM SALT 0.5% / NIACINAMIDE 4% / TRETINOIN 0.1%

HYALURONIC ACID SODIUM SALT 0.5% / NIACINAMIDE 4% / TRETINOIN 0.1%

Approved
Approval ID

8738b466-9677-687a-e053-2a91aa0a2c1f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 23, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYALURONIC ACID SODIUM SALT 0.5% / NIACINAMIDE 4% / TRETINOIN 0.1%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-2092
Product Classification
G
Generic Name
HYALURONIC ACID SODIUM SALT 0.5% / NIACINAMIDE 4% / TRETINOIN 0.1%
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 23, 2019
FDA Product Classification

INGREDIENTS (3)

TRETINOINActive
Quantity: 0.1 g in 100 g
Code: 5688UTC01R
Classification: ACTIB
HYALURONIC ACIDActive
Quantity: 0.5 g in 100 g
Code: S270N0TRQY
Classification: ACTIB
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYALURONIC ACID SODIUM SALT 0.5% / NIACINAMIDE 4% / TRETINOIN 0.1% - FDA Drug Approval Details